99mTc-MDP uptake in SPECT/CT by a bladder hernia simulating inguinal metastasis: A case report

被引:2
|
作者
Ji, Tiefeng [1 ]
Gao, Dapeng [1 ]
Chen, Bin [1 ]
Wang, Renjie [1 ]
Gao, Shi [1 ]
机构
[1] Jilin Univ, China Japan Union Hosp, Dept Nucl Med, 126 Xiantai Ave, Changchun 130033, Jilin, Peoples R China
关键词
(99m)technetium-methylene diphosphonate; single-photon emission computed tomography/computed tomography; bone scan; bladder hernia; metastasis; CT;
D O I
10.3892/ol.2016.4091
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 72-year-old male with a history of prostate cancer and high prostate specific antigen levels underwent (99m)technetium-methylene diphosphonate (Tc-99m-MDP) single-photon emission computed tomography/computed tomography (SPECT/CT), to identify bone metastasis. The patient possessed no previous history of serious illnesses or surgical procedures and no family history of malignancies. A whole-body CT scan revealed an intense MDP uptake in the right inguinal region on the anterior view, but not in the posterior view, which was suspected to be a metastatic lesion. However, there was no evidence of bone metastasis on the CT scan. In addition, an increased Tc-99m-MDP uptake was indicated on the SPECT images in the right inguinal region, which appeared to be separate from the main bladder activity. CT images of the pelvis revealed an inferior tongue-like extension of the bladder into the right inguinal region. Fused SPECT/CT axial images indicated the circular accumulation of the Tc-99m-MDP in the medial right groin, with well-defined walls that connected the accumulation to the bladder. The final diagnosis was a bladder hernia (T2N0M0), which may have been responsible for the misdiagnosis of bone metastasis due to the use of radiopharmaceuticals (Tc-99m-MDP) that were mainly excreted through urination. Considering the comprehensive situation of the patient, radical prostatectomy was performed. The bladder hernia was subsequently monitored by follow-up examination every 3 months, and remains alive and under follow-up to date.
引用
收藏
页码:1398 / 1400
页数:3
相关论文
共 50 条
  • [1] Demonstration of 99mTc-MDP Uptake in a Mobile Urinary Bladder Calculus on SPECT/CT
    Carnahan, Molly B.
    Hoang, Peter
    Eversman, William G.
    Yang, Ming
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 60 - 62
  • [2] Peritoneal Metastasis of Osteosarcoma in 99mTc-MDP SPECT/CT Imaging
    Shen, Chentian
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : e587 - e588
  • [3] Diffuse multiple organs uptake of 99mTc-MDP on SPECT/CT
    Maoqing Jiang
    Ping Chen
    Yu Chu
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1264 - 1265
  • [4] 99mTc-MDP Uptake in Implantation Metastasis of Gastric Cancer The Additional Value of SPECT/CT
    Zhao, Haimin
    Han, Jiankui
    Lv, Fengli
    Zhang, Changming
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (10) : 838 - 840
  • [5] Diffuse multiple organs uptake of 99mTc-MDP on SPECT/CT
    Jiang, Maoqing
    Chen, Ping
    Chu, Yu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1264 - 1265
  • [6] A case of accidental local pulmonary 99mTc-MDP uptake on bone SPECT/CT
    Chen, Yao
    Ning, Yu
    Liu, Xiaoji
    Cai, Min
    Li, Sijin
    CLINICAL CASE REPORTS, 2022, 10 (12):
  • [7] Quantitative analysis of bone uptake using SPECT/CT and 99mTc-MDP
    Hou, Renhua
    Cai, Jinlai
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [8] 99mTc-MDP SPECT/CT for the characterization of enostosis
    Ferrando, R.
    Damian, A.
    Gutierrez, D.
    Naula, J.
    Gutierrez, L.
    Lischinsky, E.
    Carrera, F.
    Villavicencio, M.
    Bayardo, K.
    Alonso, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S521 - S521
  • [9] 99mTc-MDP uptake in thyroid nodule: Contribution of SPECT-CT and ultrasonography
    Tuncel, M.
    Akdemir, E.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2012, 31 (01): : 49 - 50
  • [10] 99mTc-MDP SPECT/CT for Assessment of Condylar Hyperplasia
    Derlin, Thorsten
    Busch, Jasmin D.
    Habermann, Christian R.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (01) : E48 - E49